The last day awaits us at #ET2026! ✨
Today's highlights include sessions on:
✔️ Thyroids
✔️ Haemorrhoids
✔️ Exceptional cases
💻 Watch sessions on demand via the congress platform: https://t.co/8ziJ87iQuq
#embolization#interventionalradiology
Congratulations to Dr. Valeria Grillo for winning the #ET2026 Best Scientific Paper Award for her presentation "Retrospective Italian registry on DSM-TACE: experience beyond current recommendations"! 🏅
💻 Watch the presentation on demand: https://t.co/F1QRmdZhyT
#ET2026: Thank you to all who joined the Paeds in Practice hands-on workshops and to our expert faculty member, Dr. Aenov Cohen!
Interested in more hands-on training? Join us at the Paeds in Practice workshop during #CIRSE2026 & explore courses at https://t.co/CyBrWlpMvL.
Thank you to all lecturers, exhibitors, and of course attendees for making #ET2026 a great success! 🎉
➡️ Lectures and symposia are available on demand via https://t.co/kSF6SLLNd4
📅 Mark your calendar! #ET2027 will take place from June 23-26 in Berlin.
Ninguna mujer de 20 a 24 años en Inglaterra murió de cáncer cervical entre 2020 y 2024. Es la primera vez que se registran cero muertes por cáncer cérvico-uterino para este grupo de edad, y se debe a la introducción de una vacuna contra el VPH.
🎉 Celebrate 20 years of ESIR at #ET2026!
Join Dr. Aenov Cohen tomorrow, 13:00–14:00, for a paediatric trauma hands-on workshop at the ESIR booth. Register in advance to secure your spot!
🔗 https://t.co/CyBrWlpMvL
#ESIR#InterventionalRadiology#CIRSE
#ET2026 is starting off strong with a packed auditorium for the special topic session on Joints: MSK embolization! Don't forget — all sessions will be available on demand via the congress platform 👉 https://t.co/PH17JCzi65
Pictured lecturer: Yuji Okuno M.D., Ph.D
CIRSE Journals & SOP Instant Feedback at #ET2026 🚀
Stop by the booth to meet our Editors and SOPC Chairperson, share your manuscript ideas, ask peer-review questions, or learn how to get involved with the journals.
📅 Today, June 18
🕙 10:00-10:30
📌CIRSE Journals booth
Me hace especial ilusión esta foto. Carlota, nuestra fantástica R5, ha terminado su rotación en #POCUS en nuestra unidad de Ecografía Clínica, la primera desde que la acreditamos. Estamos seguros de que tendrás mucho éxito profesional 🤗
Microwave ablation technology is continuously advancing in medical settings - but when is it best to use it? Dr. Hoffmann dives into both advantages and disadvantages of this ablation therapy. Qualities that are talked about revolve around types of lesions, system efficiencies, and many more.
Tune into the full episode on Youtube: https://t.co/hnjw9vpKgG
This podcast is supported by Varian.
#VI592 #InterventionalRadiology #TumorBoard #IRad #MicrowaveAblation #Y90 #BackTable
Un antibiótico que se usa mayormente para tratar los barros (acné) mejora el pronóstico neurológico de los pacientes con EVC Isquémico (#Stroke) 🧠
Bueno, bonito y barato. (Seguro y eficaz)
💊 200 mg de carga y 100 mg c/12 h por 4 días subsecuentes en pacientes con <72 h del evento
Úsenlo YA!
https://t.co/8n2JLXuiMN
Brazilian researchers have spent decades studying how certain placenta-derived proteins influence nerve regeneration, and their breakthrough drug is now showing unprecedented results. Early trial participants with severe spinal cord injuries have regained sensation, muscle control, and in some cases the ability to walk — something long believed to be medically impossible. This treatment works by activating dormant pathways in the spinal cord that repair damaged nerve cells and encourage new neural connections.
If proven safe through large-scale clinical trials, this therapy could redefine the future of spinal injury treatment worldwide. Today, more than 27 million people live with paralysis globally, and most therapies focus only on preventing further damage rather than reversing it. A drug capable of restoring lost function could completely transform rehabilitation medicine, offering hope to millions who were told recovery was out of reach.
Experts say this breakthrough could also pave the way for new treatments for stroke recovery, traumatic brain injuries, and neurological degenerative diseases. While more testing is needed before global approval, the early results are a powerful reminder that the boundaries of medical science are constantly being rewritten.